Economic Cost of Tobacco-Related Diseases in Nigeria: a Study of three Hospitals in Ibadan, Southwest Nigeria

Owoeye, Olumide Bamidele and Olaniyan, Olanrewaju (2015): Economic Cost of Tobacco-Related Diseases in Nigeria: a Study of three Hospitals in Ibadan, Southwest Nigeria.

Abstract

Costs of tobacco-related disease can be useful evidence for important macroeconomic health policy. The costs can be enormous given that tobacco-related diseases have major adverse effect on the quality of life and productivity of affected individuals. This is the gap in tobacco-related research in Nigeria that this paper attempted to fill. This paper provides estimates of economic costs of four active tobacco-related diseases in Nigeria. This paper is a hospital-based study which utilized an exploratory survey carried out between March to September 2010 to assess and document different components of economic costs of tobacco-related diseases within the Ibadan metropolis, South West Nigeria. A structured questionnaire form was used to collect data on tobacco smoking behaviour, as well as direct and indirect costs associated with outpatient visits and hospitalization. Using the prevalence-based method of the cost of illness (COI) approach, the paper estimated that the mean total direct and indirect costs during hospitalization period were $3,142 and $2,322.95 for Stroke or Transient Ischemic attack and lung cancer respectively while the costs were$1,445.24 and $741.43 for COPD and tuberculosis respectively (in term of dollars). The paper found that direct and indirect costs were mainly paid by out of pocket by the victims and their respective families. The results further reveal that the high cost of the disease can be catastrophic for individuals from poor households. The paper thus concludes that anti-smoking measures to avoid tobacco-related diseases can reduce the economic costs of the disease.

• Item Type: MPRA Paper
• Language: English
• Keywords: Economic Cost, Tobacco-Related Disease, Direct Cost, Indirect Cost and Cost of Illness
• Subjects: I - Health, Education, and Welfare > I1 - Health; I - Health, Education, and Welfare > I1 - Health > I12 - Health Behavior

References

Abegunde D. Anderson Stanciole (2006).An estimation of the economic impact of chronic noncommunicable diseases in selected countries (WHO).

Adelekan M.I Ndom R, Obayan A.L. (1996) Monitory trends in Substance use through a repeat cross-sectional survey in a Nigerian University Drugs Education. Press. Policy 3:239-247.

Adirieje A,Uzodinma, (2006); Tobacco and the Rest Of Us. Afrihealth Information Projects; AfrihealthOptonetAssociation.http://uk.geocities.com/afrihealthoptonetassociation/AfrihealthOptonet.html

AinaBolajoko A, Adebayo T Onajole, Babatunde MO Lawal andOpeoluwa O Oyerinde (2009).Promoting Cessation and a Tobacco Free Future: Willingness ofPharmacy Students at the University of Lagos, Nigeria.Tobacco Induced Diseases, 5:13 doi:10.1186/1617-9625-5-13.

Akinroye Kingsley (2004) a paper titled ‘Nigeria: The health, Economic and Social Menace of Smoking - Time for concerted Actions’.Nigerian Heart Foundation (NHF)

Baquilod, M.M. et al (2006). The Burden of Smoking-Related Diseases and Health Care Cost of Tobacco Use.WHO-DOH, UP Manila, Philippine College of Medical Researchers Foundation.

Barcelỏ Alberto, CristianAedo, SwaprutRajpattak and Sylvia Robles (2000). The Cost of Diabetes in Latin America and The Caribbean. Bulleting of The World Health Organization WHO (2003) 81 (1).

Bloom David E., David Canning and JaypeeSevilla (2004). The Effect of Health on Economic Growth: A production Function Approach. Doi: 10.1016/j. world deve.2003.07,002 vol.32 no1 pp 1-13.

Chor BCK, Robson L, Single E. (1997) Estimating the Economic Costs of the Abuse of Tobacco, alcohol and illicit drugs: A Review of Methodologies and Canadians Data Sources. Chronic Diseases Canada 18:149-165.

Chu Vang, PhengSackda, XaysanaSombandith, SnongThongsna, BounmySisamouth, SisouphanhVidhamrly (2009). Tobacco-Related Socio Economic Cost of Stroke, Lung Cancer and COPD in Laos.The Collaborative Funding Program for Southeast Asia Tobacco Control Research.Sponsored by Research for International Tobacco Control (RITC) of the International Development Research Centre (IDRC).

Chuma (2006). Rethinking The Economic Costs of Malaria at the Household Level: Evidence from Applying A New Analytical framework In Rural Kenya. Malaria Journal.

De Beyer, J., Brigden, L.W,Debeyer, J.Brigden, L.W. (2003). Overview, In: Tobacco Control Policy. Strategies, Successes and Setbacks. The World Bank, Washington DC . pp. 1-12.

Farley TM, Meirik O, Chang CL, et al (1998). Combined oral contraceptives, smoking, andcardiovascular risk J Epidemiol Community Health 52:775-785.

Gajalakshmi V, Peto R, Kanak TS, Jha P. (2003). Smoking and Mortality from Tuberculosis and Other Diseases in India: Retrospective Study of 43000 adult male deaths and 35000 control. 362: 507-715.

Global Youth Tobacco Survey Collaborative Group. (2002). Special Report: Tobacco use among youth, students 13-15 years old in Cross River State: a cross country comparison. Tobacco Control 11: 252-270.

Golan et al (1998). Cost of Illness Approach: Social Accounting Matrix Model. America Economic Review -784

Goldman L, Weinstein MC, Williams LW (1999): Relative impact of targeted versus populationwide cholesterol interventions on the incidence of coronary heart disease. Projections of the Coronary Heart Disease Policy Model. Circulation 80:254-260.

Graham Colditz A. (1992) Economic Costs of Obesity.American Society for Clinical Nutrition.

GrimardFranque and Guy Harling (2003). The Impact of Tuberculosis on Economic Growth.A working Paper.McGill University, Montréal.

Harris Jefferey E.(1998). Cigarette Smoking practices, smoking-Related Diseases, And The Costs Of Tobacco-Related Disability Among Currently Living U.S Veterans.

Hodgson, T.A. (1998). The health care costs of smoking, New England.Journal of Medicine 338(7):470.

Howard et al (1994). Economic Cost of Alcohol and Drugs Abuse in United State.Vol 94 pp631-645.

Hsieh Chee-Ruey et al (1996). Smoking, Health Knowledge and anti- Smoking Campaign, An Empirical Study in Taiwan. Journal of Health Economics15 pp87-104.

Jean-claudeSailly, Xavier Lenne, Caroline, B. Lebrun T, Tonnel A.B, Isabelle T.L (2005) Cost of Hospitalization for Severe Acute Asthma of Patients Not Treated According to Guidelines and Recommendations: French Prospective Study of 169 Cases. European Journal of Health EconomicVol 6. No 2pp 94-101.

Jha P. Chaloupka FJ (2000). Curbing The Epidemics: Government and The Economics of Tobacco Control. The World Bank; Oxford University Press.

Jin SG, Lu BY, Yan DY, et al (1995). An Evaluation on Smoking-Induced Health Costs in China (1988-1989). Biomed Environ Sci 8:342-349,

Jittrakul L, Wimol, Eugene Salole (2006). The Economic Burden of Smoking-Related Diseases in Thailand: A Prevalence- Based Analysis. J med. Assoc Thai. 90(9), 1925-1935.

Joel E segel (2006). Cost of Illness Studies – A primer. RTI International, RTI- UNC center of Exellence in Health Promotion Economics.

John R.M, H.Y Sung, W. Max (2009). Economic Cost of Tobacco Use in India, 2004.Tobacco Control 18:138-143 doi:10.133/tc 2008027466.

LaxminarayanRamanan, Eili Klein, Christopher Dye, Katherine Floyd, Sarah Darley, OlusojiAdeyi (2007). Economic Benefit of Tuberculosis Control.The World Bank Human Development Network Health, Nutrition and Population Team.A Policy Research Working Paper 4295.

Leal Jose, Ramon LuengoF,Alastair Gray Milee R. (2006). Economic Burden of Cardiovascular Diseases in The Enlarged European Union. European Heart Journal.27, 1610-1619.

Lightwood James (2003) The Economics of Smoking and Cardiovascular Diseases. Journal of Health EconomicsVol 64 No 1 pp 39-78.

Lightwood James, David Collins, Helen Lapsley, and Thomas E. Novotny (2000).Estimating the Costs of Tobacco Use.

Lightwood M.James, Alexi Dinno, Stanton A, Glantz (2008).Effect of the California Tobacco Control Program on Personal Health Care Expenditures. Journal of Pmed0050178 PLosmed 5(8) e178.doi10;1371

Louie S et al (2002). Economic Cost Of HIV Infection: An Employer’s Perspective. The European Journal of Health EconomicsVol 3, No 4 pp 226-234.

McGhee S.M, L.M Ho, H. M Lapsley, J. Chau, W.L Cheung, S.Y Ho, M. Pow, T.H Lam, A.J Hedley (2006). Cost of Tobacco-Related Diseases, Including Passive Smoking in Hong Kong.Tobacco Control 15:125-130, doi:10,1136/ic2005.013292.

National Asthma Campaign (2003). Report on the cost of asthma in Australia. www.nationalasthma.org.au/publications/costs/costindx.html.

Ndom, R., Adelekan, M., 1996. Psychosocial correlates of substance use among undergraduates in Ilorin University, Nigeria. East Afr. Med. J. 73, 541–547.

Neubauer Simone, Robert Welte, Alexandra Beiche, Hans-Helmut Koemg, Katharina Buech and Remer Leidi (2006).Mortality, Morbidity and Costs attributable to Smoking in Germany.Update and a 10 years comparision.Tob control15(6) pp 464-471.

Oluwafemi .AShafey O, Dolwick S. Guidon G.E. (2003).Tobacco Control Country Profiles, seconded,.Regional Summary for the Africa Region.American Cancer Society,Atlanta Pp 27-31.

Okojie, O.H., Isah, E.C. and Okoro, E. (2000). Assessment of health of senior executives in a developing country: case study of Benin City, Southern Nigeria.Public Health 114: 273-275.

Owoeye Akinsola (2010). “Nigeria Tobacco Control Bill, The World is Watching” A Comment on Nigerian Business day Newspaper.

Owusu-Dabo E, S Lewis, A McNeill, A Gilmore,and J Britton (2009).Smoking Uptake and Prevalence in Ghana.Doi: 10.1136/tc 2009 030635 18(5) 365-370.

Palmer CS, Miller B, Halpern MT, Geiter LJ (1998). A Model of the Cost-effectiveness of Directly Observed Therapy for Treatment of Tuberculosis.Journal of Public Health Management and Practice;4(3):1–13

Palmer CS, Revicki DA, Genduso LA, Hamilton SH, Brown RE (1998) A cost-effectiveness clinical decision analysis model for schizophrenia. America Journal of Management Care 4:345-355.

Peto R, Doll R, Boreham J, Sutherland I (2004) Mortality in relation to smoking: 50 years'observations on male British doctors. BMJ 328:1519 8.

Rahman A, Ali Z,Rahman T (2004); An Appetite For Nicotine; An epidemiological Analysis Of Tobacco Control In Bangladesh, Economics Of Tobacco Control Paper number 16, HNP discussion paper, World Health Organization.

Rice, D.P., T.A. Hodgson, P. Sinsheimer, W. Browner and A.N. Kopstein (1986).The economic costs of the health effects of smoking, 1984, Milbank Quarterly 64(4):489-547.

Ross Hana, Dang Vu, Trung and Vu XhanPhu (2007). The Cost of Smoking in Vietnam: The case of Inpatient Care. Tobacco Control Journal 16(6) pp 405-409.

Sauerborn R., A. Nougtary, M. Hien and H. J Diesfeld(1996). Seasonal Variations of Household Costs of Illness in Burkina Faso.Soc. Sci med vol 43, no 3 pp 281-290.

Shearer A, Scuffham P, Mollon P.(2004).The cost of coronary artery disease in the UK. Br J Cardiol; 11: 218–23.

Single E, Robson L, Xie X, Rehm J (1998).The Economic Cost of Alcohol, Tobacco and Illicit Drug in Canada for 1992.Pmedvol 93 no 7 pp 991-1006(16).

TediosiTabrizio, Fabio Parazzini, LivioGarahiri (2000), Coast of SchziphreniaStudiu: A Methodological Review. Health Economics in Prevention and Care.Vol 1 No 1 pp 14-19.

The Canadian Burden of Illness Study Group (1998) Burden of illness of multiple sclerosis: Part I – cost of illness. Can J NeurolSci; 25: 23–30.

Warner, K.E., T.A. Hodgson and C.E. Carroll (1999).The medical costs of smoking in the United States: estimates, their validity, and their implications, Tobacco Control8:290-300.

World Health Organization (2007).Impact of Tobacco-Related Illnesses in Bangladesh.

World Health Organization Regional Office for Africa (2005).Implementation of the Framework.Convention on Tobacco Control in the African Region. Current Status and the Way Forward.http://www.afro.who.int/rc55/documents/afr_rc55_13_tobacco_control.pdf (accessed on 28th November 2005)

World Health Organization, (2004). Tobacco Increase the Poverty of Countries. http://www.who.int/tobacco/communications/events/wntd/2004/tobaccofacts_nations/en.pdf (accessed on 29th November 2005).